Inari Medical, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 126.37 million compared to USD 96.2 million a year ago. Net income was USD 3.16 million compared to net loss of USD 10.15 million a year ago. Basic earnings per share from continuing operations was USD 0.06 compared to basic loss per share from continuing operations of USD 0.19 a year ago. Diluted earnings per share from continuing operations was USD 0.05 compared to diluted loss per share from continuing operations of USD 0.19 a year ago.
For the nine months, sales was USD 361.54 million compared to USD 275.7 million a year ago. Net income was USD 3.03 million compared to net loss of USD 23.47 million a year ago. Basic earnings per share from continuing operations was USD 0.05 compared to basic loss per share from continuing operations of USD 0.45 a year ago. Diluted earnings per share from continuing operations was USD 0.05 compared to diluted loss per share from continuing operations of USD 0.45 a year ago.